Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Selenium intakes may be "suboptimal" for prostate cancer risk reduction -- Harvard study.

This article was originally published in The Tan Sheet

Executive Summary

SELENIUM RECOMMENDED INTAKE MAY BE "SUBOPTIMAL" FOR PROSTATE CANCER risk reduction, Kazuko Yoshizawa, Harvard School of Public Health, et al., state in a study in the Aug. 19 Journal of the National Cancer Institute. The researchers report a "strong inverse association between the prediagnostic selenium level assessed" in study participants and the risk of advanced prostate cancer. Higher selenium intake levels among participants, as measured in toenail clippings collected by the researchers, were found to be associated with a lower risk of advanced prostate cancer.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel